Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 10 results.
User Information
Export Records
  1. 1.   Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine
  2. Boltz, V. F.; Zheng, Y.; Lockman, S.; Hong, F. Y.; Halvas, E. K.; McIntyre, J.; Currier, J. S.; Chibowa, M. C.; Kanyama, C.; Nair, A.; Owino-Ong'or, W.; Hughes, M.; Coffin, J. M.; Mellors, J. W.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, May; 108(22): 9202-9207.
  1. 2.   Ethnoepidemiology of HTLV-1 related diseases: Ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal
  2. Sonoda, S.; Li, H. C. A.; Tajima, K.
  3. Cancer Science. 2011, Feb; 102(2): 295-301.
  1. 3.   Geographic Variation in the Prevalence of Kaposi Sarcoma-Associated Herpesvirus and Risk Factors for Transmission
  2. de Sanjose, S.; Mbisa, G.; Perez-Alvarez, S.; Benavente, Y.; Sukvirach, S.; Nguyen, T. H.; Shin, H. R.; Pham, T.; Thomas, J.; Lazcano, E.; Matos, E.; Herrero, R.; Munoz, N.; Molano, M.; Franceschi, S.; Whitby, D.
  3. Journal of Infectious Diseases. 2009 199(10): 1449-1456.
  1. 4.   Cytochrome P4502B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda
  2. Penzak, S. R.; Kabuye, G.; Mugyenyi, P.; Mbamanya, F.; Natarajan, V.; Alfaro, R. M.; Kityo, C.; Formentini, E.; Masur, H.
  3. HIV Medicine. 2007, Mar; 8(2): 86-91.
  1. 5.   Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy
  2. Palmer, S.; Boltz, V.; Maldarelli, F.; Kearney, M.; Halvas, E. K.; Rock, D.; Falloon, J.; Davey, R. T.; Dewar, R. L.; Metcalf, J. A.; Mellors, J. W.; Coffin, J. M.
  3. Aids. 2006, Mar; 20(5): 701-710.
  1. 6.   Single dose nevirapine combined with a short course of combivir for prevention of mother to child transmission of HIV-1 can significantly decrease the subsequent development of maternal and infant resistant virus
  2. McIntyre, J.; Martinson, N.; Gray, G. E.; Hall, D. B.; Boltz, V.; Palmer, S.; Coffin, J.; Mellors, J.; Hopley, M.; Kimura, T.; Robinson, P.; Mayers, D. L.
  3. Antiviral Therapy. 2005 10(4): S4-S4.
  1. 7.   Regulation of the cell-surface expression of an HTLV-1 binding protein in human T cells during immune activation
  2. Nath, M. D.; Ruscetti, F. W.; Petrow-Sadowski, C.; Jones, K. S.
  3. Blood. 2003 101(8): 3085-3092.
  1. 8.   Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica
  2. Hisada, M.; Maloney, E. M.; Sawada, T.; Miley, W. J.; Palmer, P.; Hanchard, B.; Goedert, J. J.; Manns, A.
  3. Clinical Infectious Diseases. 2002 34(12): 1551-1557.
  1. 9.   Blood Collection On Filter Paper - a Practical Approach to Sample Collection For Studies of Perinatal Hiv Transmission
  2. Biggar, R. J.; Miley, W.; Miotti, P.; Taha, T. E.; Butcher, A.; Spadoro, J.; Waters, D.
  3. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1997 14(4): 368-373.
  1. 10.   HIV pharmacogenetics and pharmacogenomics: From bench to bedside
  2. Limou, Sophie; Winkler,Cheryl; Wester, C. William
  3. 2019; 185-222.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel